Société de Therapeutique Marocaine S.A. (CBSE:SOT)
Morocco · Delayed Price · Currency is MAD 360.00
-8.00 (-2.17%)
At close: Aug 28, 2026
CBSE:SOT Cash Flow Statement
Financials in millions MAD. Fiscal year is January - December.
Millions MAD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 385.53 | 315.29 | 262.76 | 266.62 | 278.85 |
Depreciation & Amortization | 58.77 | 67.96 | 54.64 | 57.18 | 54.63 |
Loss (Gain) From Sale of Assets | -3.35 | -16.36 | -0.12 | 5.85 | -0.03 |
Loss (Gain) on Equity Investments | 1.36 | 0.64 | 0.33 | 0.02 | 0.12 |
Other Operating Activities | 81.99 | 60.28 | -0.79 | 0.39 | 24.02 |
Change in Other Net Operating Assets | -63.6 | -194.15 | -216.86 | -173.62 | -29.9 |
Operating Cash Flow | 460.69 | 233.65 | 99.95 | 156.43 | 327.69 |
Operating Cash Flow Growth | 97.17% | 133.78% | -36.11% | -52.26% | 249.17% |
Investing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -78.28 | -112.71 | -117.67 | -70.1 | -62.56 |
Sale of Property, Plant & Equipment | 0.01 | 0.04 | 73.31 | 0 | 0.03 |
Cash Acquisitions | -1,094 | - | - | - | - |
Divestitures | - | 23.37 | - | - | - |
Investment in Securities | - | - | - | -21.6 | - |
Other Investing Activities | 1.41 | 0 | 3.48 | 9 | - |
Investing Cash Flow | -1,171 | -87.45 | -42.8 | -82.78 | -62.55 |
Financing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | 550.76 | 200 | 154.2 | 80.21 | 10.21 |
Long-Term Debt Repaid | -220.71 | -174.4 | -16.22 | -40.19 | -40.43 |
Net Debt Issued (Repaid) | 330.05 | 25.6 | 137.98 | 40.03 | -30.22 |
Issuance of Common Stock | 630.43 | - | - | - | - |
Common Dividends Paid | -201.6 | -122.4 | -180 | -180 | -151.2 |
Other Financing Activities | 25.48 | -16.34 | -23.93 | 20.03 | -18.83 |
Financing Cash Flow | 784.35 | -113.14 | -65.95 | -119.95 | -200.25 |
Net Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 0.22 | -0.33 | -0.06 | 0.21 | -0.21 |
Miscellaneous Cash Flow Adjustments | -0 | - | - | - | - |
Net Cash Flow | 73.98 | 32.74 | -8.86 | -46.09 | 64.69 |
Free Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 382.42 | 120.94 | -17.72 | 86.33 | 265.13 |
Free Cash Flow Growth | 216.21% | - | - | -67.44% | 664.47% |
Free Cash Flow Margin | 11.86% | 4.29% | -0.71% | 3.75% | 12.90% |
Free Cash Flow Per Share | 10.05 | 3.36 | -0.49 | 2.40 | 7.37 |
Levered Free Cash Flow | 286.24 | 84.37 | -63.76 | 67.63 | 338.99 |
Unlevered Free Cash Flow | 300.9 | 103.87 | -51.03 | 73.9 | 344.68 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Income Tax Paid | 195.23 | 153.88 | 146.34 | 154.5 | 112.47 |
Change in Working Capital | -63.6 | -194.15 | -216.86 | -173.62 | -29.9 |